Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives
Prakash Chelladurai, Werner Seeger, Soni Savai Pullamsetti
European Respiratory Review (2016) Vol. 25, Iss. 140, pp. 135-140
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

DNA Methylation and Histone Modification in Hypertension
Shaunrick Stoll, Charles Wang, Hongyu Qiu
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 4, pp. 1174-1174
Open Access | Times Cited: 105
Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy
Prakash Chelladurai, Olivier Boucherat, Kurt R. Stenmark, et al.
British Journal of Pharmacology (2019) Vol. 178, Iss. 1, pp. 54-71
Open Access | Times Cited: 100
Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension
Prakash Chelladurai, Carsten Kuenne, Alice Bourgeois, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 648
Closed Access | Times Cited: 39
Challenges and opportunities in targeting epigenetic mechanisms for pulmonary arterial hypertension treatment
Jie Feng, Yunman Liu, Kai Li, et al.
International Journal of Pharmaceutics (2025) Vol. 672, pp. 125332-125332
Closed Access | Times Cited: 1
FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension
Alice Bourgeois, Caroline Lambert, Karima Habbout, et al.
Journal of Molecular Medicine (2017) Vol. 96, Iss. 2, pp. 223-235
Closed Access | Times Cited: 80
Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled
Anna R. Hemnes, Marc Humbert
European Respiratory Review (2017) Vol. 26, Iss. 146, pp. 170093-170093
Open Access | Times Cited: 79
MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways
Zongye Cai, Jian Li, Zhuang Qi, et al.
Experimental & Molecular Medicine (2018) Vol. 50, Iss. 4, pp. 1-11
Open Access | Times Cited: 78
Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs
Kashif Rafiq Zahid, Umar Raza, Jidong Chen, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 12, pp. 1937-1947
Open Access | Times Cited: 53
Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development
Jaydev K. Dave, Vineeta Jagana, Radoslav Janoštiak, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension
Yuan Jiang, Shasha Song, Jingxin Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment
Łukasz Wołowiec, Martyna Mędlewska, Joanna Osiak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9735-9735
Open Access | Times Cited: 13
Epigenetic Modulation in the Initiation and Progression of Pulmonary Hypertension
Xinyu Cheng, Yu Wang, Lizhong Du
Hypertension (2019) Vol. 74, Iss. 4, pp. 733-739
Open Access | Times Cited: 35
Isoform-specific characterization of class I histone deacetylases and their therapeutic modulation in pulmonary hypertension
Prakash Chelladurai, Swati Dabral, Sobha Rani Basineni, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 29
Novel SMARCA4 Variant in an Infant With Atypical Teratoid Rhabdoid Tumor
Shria K. Haldipurkar, Sudarshawn Damodharan, Pamela Rathbun, et al.
Journal of Pediatric Hematology/Oncology (2025)
Closed Access
Epigenetic Control of Alveolar Macrophages: Impact on Lung Health and Disease
Nirmal Parajuli, Kalpana Subedi, Xzaviar Kaymar Solone, et al.
Cells (2025) Vol. 14, Iss. 9, pp. 640-640
Open Access
Hypoxia-induced changes in plasma micro-RNAs correlate with pulmonary artery pressure at high altitude
Birgit Blissenbach, Christos T. Nakas, Martin Krönke, et al.
AJP Lung Cellular and Molecular Physiology (2017) Vol. 314, Iss. 1, pp. L157-L164
Closed Access | Times Cited: 29
Mechanisms Contributing to the Dysregulation of miRNA-124 in Pulmonary Hypertension
Hui Zhang, A. Laux, Kurt R. Stenmark, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3852-3852
Open Access | Times Cited: 18
Perillyl alcohol and quercetin modulate the expression of non-coding RNAs MIAT, H19, miR-29a, and miR-33a in pulmonary artery hypertension in rats
Soodeh Rajabi, Hamid Najafipour, Mozhgan Sheikholeslami, et al.
Non-coding RNA Research (2022) Vol. 7, Iss. 1, pp. 27-33
Open Access | Times Cited: 13
1,25(OH) 2 D 3 attenuates pulmonary arterial hypertension via microRNA-204 mediated Tgfbr2/Smad signaling
Yu Hua, Min Xu, Yizhi Dong, et al.
Experimental Cell Research (2017) Vol. 362, Iss. 2, pp. 311-323
Closed Access | Times Cited: 24
Future perspectives in pulmonary arterial hypertension
Gérald Simonneau, Marius M. Hoeper, Vallerie V. McLaughlin, et al.
European Respiratory Review (2016) Vol. 25, Iss. 142, pp. 381-389
Open Access | Times Cited: 23
A peripheral system disease—Pulmonary hypertension
Yang Sun, Chen Chen, Yan Qian, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116787-116787
Open Access | Times Cited: 2
G9a/GLP Targeting Ameliorates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
Charifa Awada, Alice Bourgeois, Sarah‐Eve Lemay, et al.
American Journal of Respiratory Cell and Molecular Biology (2023) Vol. 68, Iss. 5, pp. 537-550
Closed Access | Times Cited: 5
Non-Coding RNA Networks in Pulmonary Hypertension
Hongbin Zang, Qiongyu Zhang, Xiaodong Li
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 12
Critical effects of epigenetic regulation in pulmonary arterial hypertension
Dewei Chen, Wenxiang Gao, Shouxian Wang, et al.
Cellular and Molecular Life Sciences (2017) Vol. 74, Iss. 20, pp. 3789-3808
Open Access | Times Cited: 13
Future Perspectives of Pulmonary Hypertension Treatment.
Chih‐Hsin Hsu, Wei‐Chun Huang, Wei‐Ting Chang
PubMed (2022) Vol. 38, Iss. 4, pp. 435-442
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top